Moreover, its HAT-inhibitory activity has been linked to the regulation of microRNAs, epithelial–mesenchymal transition (EMT), and cancer stem cell renewal, establishing garcinol as a multifaceted compound that integrates epigenetic control with transcriptional and signaling network regulation in cancer. This evidence concerns the gene TMPRSS11D and cancer.